Partner? Huh? Myrexis has plenty of cash, and excellent prospects of being seen as a good credit risk in an easy lending environment when they need more cash. Trade half the prospects of a potential blockbuster for cash you don't need? Not a great move.
I'd expect the final 2b results to be presented in a meeting no later than July, which puts us within three months of hearing a topline summary. Probably a little sooner. Later actually suggests an intention to publish in a top-tier journal, which is good (You don't put up with Arnold f'ing Relman for the sake of a finding that'll be forgotten in a year).